Medicare Prescription Payment Plan for GLP-1s: Spread 2027 Costs
Yes. If a Part D-covered GLP-1 leaves you with a large pharmacy bill in January, the Medicare Prescription Payment Plan lets you pay $0 at the counter and get monthly bills from your plan instead, with no interest or fees. It does not lower your total cost, which is still capped at $2,400 for 2027. You can opt in now, during Open Enrollment, so it is in place for your first fill on January 1.
Key takeaways
- Every Medicare drug plan, including Medicare Advantage plans with drug coverage, must offer the payment plan, and joining is free.
- It spreads covered Part D costs across the year; it does not reduce them. The 2027 out-of-pocket cap is $2,400 and the maximum deductible is $700.
- Bills are capped each month by a federal formula, and plans cannot charge interest or late fees.
- It helps most when your costs are high early in the year. It does not apply to the $50 Medicare GLP-1 Bridge copay, which sits outside Part D.
- Missed bills trigger at least a two-month grace period before removal, and your drug coverage itself cannot be cancelled over it.
Rules and figures checked October 19, 2026 against Medicare.gov, CMS, the federal regulation and the sources linked below. Ask your plan to confirm its billing process in writing.
Why January is the expensive month
For 2027, no Part D plan can have a deductible above $700, and the out-of-pocket cap is $2,400, up from $615 and $2,100 in 2026 (Medicare.gov). Both reset January 1. If your plan applies the deductible to your GLP-1's tier, your first one or two fills of the year can absorb most or all of that $700 before cost-sharing drops.
That front-loading is the problem the payment plan solves. CMS says "enrollees with high cost sharing earlier in the plan year are more likely to benefit from the program" (CMS fact sheet).
How the payment plan works
Medicare.gov describes it as "a payment option that works with your current drug coverage." All plans offer it, participation is voluntary, and "there's no cost to participate." It also states plainly that it "doesn't save you money or lower your drug costs" (Medicare.gov).
The federal rule behind it, 42 CFR 423.137, sets these terms (42 CFR 423.137):
- $0 at the pharmacy. You pay nothing at the counter for covered Part D drugs; the plan bills you monthly.
- No interest or fees. Plans "must not charge late fees, interest payments, or other fees."
- A monthly cap. In your first month, the most you can be billed is the yearly out-of-pocket cap minus what you have already paid, divided by the months left in the year. In later months, it is your unbilled balance plus new costs, divided by the months left.
- Join any time. You can opt in before the plan year or during it. CMS says plans must process requests made before the year within 10 calendar days and requests during the year within 24 hours (CMS).
- Automatic renewal. Plans must renew participation for the next year automatically, with a notice sent after Open Enrollment ends.
A worked example (hypothetical)
These numbers are illustrative, not your plan's costs. Assume someone's covered GLP-1 and other Part D drugs produce $1,000 of out-of-pocket costs in January, $800 in February and $600 in March, reaching the $2,400 cap. After that, they pay $0 for covered drugs for the rest of 2027. They opted in before January 1.
| Month (2027) | Costs incurred at pharmacy | Paid at pharmacy | Payment plan bill |
|---|---|---|---|
| January | $1,000 | $0 | $200.00 ($2,400 ÷ 12) |
| February | $800 | $0 | $145.45 (($800 unbilled + $800) ÷ 11) |
| March | $600 | $0 | $205.45 (($1,454.55 + $600) ÷ 10) |
| April to December | $0 | $0 | $205.45 each month |
| Year total | $2,400 | $0 | $2,400 (rounded) |
Hypothetical example applying the monthly cap formula in 42 CFR 423.137 to the 2027 $2,400 cap listed on Medicare.gov. Your plan's bills may differ by cents due to rounding.
Without the payment plan, the same person pays $1,000 in January, $800 in February and $600 in March. With it, the largest bill is about $205. The total is identical either way.
Timing matters. If the same person joined in July instead, the balance would be spread over only six months, so each bill would be larger. That is why opting in during Open Enrollment works better for a predictable January spike.
If Part D will not cover your GLP-1
The payment plan only works for drugs your Part D plan covers; if yours is denied, you can see what self-pay programs currently charge, but partner programs cannot bill Medicare.
Paid links. We may earn a commission; it never changes what we write. See all options. Compounded medications are not FDA-approved.
Who benefits, and who should skip it
| Your situation | Likely fit | Why |
|---|---|---|
| Part D-covered GLP-1 with deductible or coinsurance costs early in the year | Good | Large early costs are spread across 12 months |
| Expect to reach the $2,400 cap | Good | Bills are spread over the year instead of front-loaded |
| Low, even monthly copays | Little benefit | Your costs are already spread out |
| Getting Extra Help | Usually not | CMS says Extra Help is the better support for these enrollees |
| Wegovy, Zepbound or Foundayo through the GLP-1 Bridge | Does not apply to those fills | Bridge fills are outside Part D, at $50 a month |
Source: CMS fact sheet; 42 CFR 423.137; Medicare.gov. Checked October 19, 2026.
The Bridge point trips people up. The payment plan's monthly cap applies only to covered Part D drugs (42 CFR 423.137). CMS says the Bridge operates outside the Part D benefit, and that no part of the $50 copay counts toward your out-of-pocket costs (CMS). If the Bridge is your only expensive prescription, you have nothing for the payment plan to spread.
Pharmacies may hand you a "Likely to Benefit" notice. In its guidance for the program's first year (2025), CMS required plans to alert the pharmacy when an enrollee who has not opted in has cost-sharing of "$600 or more" for a single covered drug, and the pharmacy then gives the enrollee that notice (CMS). It is information, not a requirement to join.
What happens if you miss a bill
The regulation is fairly forgiving, but missed bills still have consequences (42 CFR 423.137):
- The plan must send a failure-to-pay notice, and you get a grace period of at least two months.
- If you still have not paid when the grace period ends, the plan can remove you from the payment plan. You still owe the balance, though the plan cannot demand immediate lump-sum repayment.
- The plan cannot drop you from your Part D coverage, or refuse to enroll you later, because of unpaid payment plan bills.
- A plan can block you from opting in the following year only if you still owe it an overdue balance.
- You can be reinstated for good cause, or at the plan's discretion once the overdue amount is paid.
You can also leave voluntarily during the year. The plan must process that within three calendar days. After that, you pay the pharmacy directly again. You still owe the costs you ran up while you were in the program, so ask the plan how it will bill the remaining balance.
How to opt in for January 1, 2027
- Pick your 2027 Part D or Medicare Advantage drug plan by December 7, 2026. Our 2027 plan guide for GLP-1 users covers how to compare them.
- Call the plan or visit its website and ask for the Medicare Prescription Payment Plan election form or phone election. Medicare.gov directs enrollees to their plan for details (Medicare.gov).
- Ask for written confirmation of your effective date. Requests before the year must be processed within 10 calendar days.
- If you joined in 2026 and are staying in the same plan, check whether you were renewed automatically, and watch for the renewal notice after December 7.
- Keep the bills on your calendar. Missing one starts the grace period clock.
Questions to ask your plan
- "If I opt in now, will it be active for my first fill on January 1, 2027?"
- "How will I receive bills, and what payment methods do you accept?"
- "Was I automatically renewed from 2026, and how do I opt out if I want to?"
- "Is my GLP-1 covered by Part D for my diagnosis, or am I using the Bridge?"
Compare care options before choosing a program
If Medicare coverage is denied or the cost is still out of reach, compare current self-pay GLP-1 options and their published prices.
Paid links. We may earn a commission; it never changes what we write. See all options. Compounded medications are not FDA-approved.
Frequently asked questions
Does the Medicare Prescription Payment Plan lower what I pay for my GLP-1?
No. Medicare.gov says it doesn't save you money or lower your drug costs. It spreads covered Part D costs, which are capped at $2,400 for 2027, into monthly bills with no interest or fees.
Can I sign up before January 1, 2027?
Yes. You can opt in before the plan year or any time during it. CMS says plans must process requests made before the year within 10 calendar days.
Does the payment plan cover the $50 Medicare GLP-1 Bridge copay?
No. The payment plan applies only to covered Part D drugs, and CMS says the Bridge operates outside the Part D benefit.
What happens if I miss a payment plan bill?
You get a failure-to-pay notice and a grace period of at least two months. If the bill is still unpaid, the plan can remove you from the payment plan, but it cannot cancel your Part D coverage over it.
Do I have to sign up again every year?
Under the federal rule, plans must automatically renew participation for the next year and send a renewal notice after Open Enrollment ends. You can opt out if you no longer want it.
Sources
- Medicare Prescription Payment Plan (Medicare.gov)
- 42 CFR 423.137, Medicare Prescription Payment Plan (Cornell LII)
- Medicare Prescription Payment Plan final part one guidance fact sheet (CMS)
- Medicare GLP-1 Bridge (CMS)
- Weight loss drugs: Medicare GLP-1 Bridge (Medicare.gov)
- Medicare.gov: Costs for Medicare drug coverage
Medical disclaimer: This article is general information, not medical advice, and does not replace a licensed clinician who knows your history. Approvals, labels, coverage and prices change; check the linked sources and talk with your prescriber or pharmacist before making decisions about any medication.